172 related articles for article (PubMed ID: 11180243)
1. Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers.
Hackshaw AK; Wald NJ
Prenat Diagn; 2001 Jan; 21(1):58-61. PubMed ID: 11180243
[TBL] [Abstract][Full Text] [Related]
2. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.
Rudnicka AR; Wald NJ; Huttly W; Hackshaw AK
Prenat Diagn; 2002 Oct; 22(10):893-7. PubMed ID: 12378572
[TBL] [Abstract][Full Text] [Related]
3. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
Wald NJ; Morris JK; Ibison J; Wu T; George LM
Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
[TBL] [Abstract][Full Text] [Related]
4. Second-trimester maternal serum quadruple test for Down syndrome screening: a Taiwanese population-based study.
Shaw SW; Lin SY; Lin CH; Su YN; Cheng PJ; Lee CN; Chen CP
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):30-4. PubMed ID: 20466289
[TBL] [Abstract][Full Text] [Related]
5. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Benn PA; Ying J; Beazoglou T; Egan JF
Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
[TBL] [Abstract][Full Text] [Related]
6. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
7. Second trimester serum markers.
Canick JA; MacRae AR
Semin Perinatol; 2005 Aug; 29(4):203-8. PubMed ID: 16104669
[TBL] [Abstract][Full Text] [Related]
8. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
[TBL] [Abstract][Full Text] [Related]
9. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
[TBL] [Abstract][Full Text] [Related]
10. Apparently low maternal serum inhibin A levels in second-trimester screening.
Lambert-Messerlian GM; Keren DF; Raphtis CS; Byberg K; Canick JA
Prenat Diagn; 2005 Oct; 25(10):967-8. PubMed ID: 16193465
[No Abstract] [Full Text] [Related]
11. Effect of maternal age curve on the predicted detection rate in maternal serum screening for Down syndrome.
Cuckle HS
Prenat Diagn; 1998 Nov; 18(11):1127-30. PubMed ID: 9854719
[TBL] [Abstract][Full Text] [Related]
12. [Specificity of biochemical markers of pregnancy second trimester].
Salazar López R; Ibarra Gallardo AL; Iduma Meléndrez M; Leyva Bojórquez R
Ginecol Obstet Mex; 2007 Oct; 75(10):608-14. PubMed ID: 18800579
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
14. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
15. Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.
Huang T; Boucher K; Summers AM
Prenat Diagn; 2007 Dec; 27(12):1138-42. PubMed ID: 17960787
[TBL] [Abstract][Full Text] [Related]
16. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
Christiansen M; Nørgaard-Pedersen B
Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
Wald NJ; Watt HC; George L
Prenat Diagn; 1996 Oct; 16(10):923-6. PubMed ID: 8938061
[TBL] [Abstract][Full Text] [Related]
18. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
Huttly W; Rudnicka A; Wald NJ
Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
[TBL] [Abstract][Full Text] [Related]
19. Inclusion of serum marker measurements from a previous pregnancy improves Down syndrome screening performance.
Larsen SO; Christiansen M; Nørgaard-Pedersen B
Prenat Diagn; 1998 Jul; 18(7):706-12. PubMed ID: 9706652
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers.
Palomaki GE; Neveux LM; Knight GJ; Haddow JE
Prenat Diagn; 2003 Mar; 23(3):243-7. PubMed ID: 12627428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]